BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16916890)

  • 1. Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals.
    Ansari AW; Bhatnagar N; Dittrich-Breiholz O; Kracht M; Schmidt RE; Heiken H
    Int Immunol; 2006 Oct; 18(10):1443-51. PubMed ID: 16916890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings.
    Ansari AW; Schmidt RE; Heiken H
    Clin Immunol; 2007 Oct; 125(1):1-4. PubMed ID: 17707134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
    Shete A; Dhayarkar S; Dhamanage A; Kulkarni S; Ghate M; Sangle S; Medhe U; Verma V; Rajan S; Hattori T; Gangakhedkar R
    AIDS Res Ther; 2020 Jul; 17(1):43. PubMed ID: 32678033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
    Thames AD; Briones MS; Magpantay LI; Martinez-Maza O; Singer EJ; Hinkin CH; Morgello S; Gelman BB; Moore DJ; Heizerling K; Levine AJ
    AIDS; 2015 Jul; 29(12):1483-91. PubMed ID: 26244388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.
    Scagnolari C; Monteleone K; Selvaggi C; Pierangeli A; D'Ettorre G; Mezzaroma I; Turriziani O; Gentile M; Vullo V; Antonelli G
    Immunobiology; 2016 Feb; 221(2):282-90. PubMed ID: 26563749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW; Justement JS; Lempicki RA; Yang J; Dennis G; Hallahan CW; Sanford C; Pandya P; Liu S; McLaughlin M; Ehler LA; Moir S; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1908-13. PubMed ID: 12552096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.
    Sabbatucci M; Covino DA; Purificato C; Mallano A; Federico M; Lu J; Rinaldi AO; Pellegrini M; Bona R; Michelini Z; Cara A; Vella S; Gessani S; Andreotti M; Fantuzzi L
    Retrovirology; 2015 Jan; 12():4. PubMed ID: 25608886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.
    Giri MS; Nebozyhn M; Raymond A; Gekonge B; Hancock A; Creer S; Nicols C; Yousef M; Foulkes AS; Mounzer K; Shull J; Silvestri G; Kostman J; Collman RG; Showe L; Montaner LJ
    J Immunol; 2009 Apr; 182(7):4459-70. PubMed ID: 19299747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects.
    Patro SC; Pal S; Bi Y; Lynn K; Mounzer KC; Kostman JR; Davuluri RV; Montaner LJ
    J Virol; 2015 Jan; 89(1):799-810. PubMed ID: 25355877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
    Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
    Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
    Covino DA; Sabbatucci M; Fantuzzi L
    Curr Drug Targets; 2016; 17(1):76-110. PubMed ID: 26687605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.
    Borkowsky W; Yogev R; Muresan P; McFarland E; Frenkel L; Fenton T; Capparelli E; Moye J; Harding P; Ellis N; Heckman B; Kraimer J
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):401-11. PubMed ID: 18327977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
    Heggelund L; Damås JK; Yndestad A; Holm AM; Mūller F; Lien E; Espevik T; Aukrust P; Frøland SS
    Clin Exp Immunol; 2004 Oct; 138(1):116-21. PubMed ID: 15373913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.
    Wu JQ; Sassé TR; Saksena MM; Saksena NK
    Virol J; 2013 Dec; 10():361. PubMed ID: 24370116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T-cell recovery and clinical outcome in HIV-1-infected patients exposed to multiple antiretroviral regimens: partial control of viremia is associated with favorable outcome.
    Brigido L; Rodrigues R; Casseb J; Custodio RM; Fonseca LA; Sanchez M; Duarte AJ
    AIDS Patient Care STDS; 2004 Apr; 18(4):189-98. PubMed ID: 15142349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load.
    Pulliam L; Sun B; Rempel H
    J Neuroimmunol; 2004 Dec; 157(1-2):93-8. PubMed ID: 15579285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia.
    Raymond AD; Gekonge B; Giri MS; Hancock A; Papasavvas E; Chehimi J; Kossenkov AV; Nicols C; Yousef M; Mounzer K; Shull J; Kostman J; Showe L; Montaner LJ
    J Leukoc Biol; 2010 Sep; 88(3):589-96. PubMed ID: 20551211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors.
    Wu JQ; Sassé TR; Wolkenstein G; Conceicao V; Saksena MM; Soedjono M; Perera SS; Wang B; Dwyer DE; Saksena NK
    Virology; 2013 Jan; 435(2):308-19. PubMed ID: 23158100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.
    Younes SA; Yassine-Diab B; Dumont AR; Boulassel MR; Grossman Z; Routy JP; Sekaly RP
    J Exp Med; 2003 Dec; 198(12):1909-22. PubMed ID: 14676302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.